moving therapies from the relapse/refractory setting to the frontline
Published 5 years ago • 93 plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
5:40
approaching treatment for relapsed/refractory all
-
9:21
relapsed/refractory treatment: the magnify regimen
-
3:56
treatment approaches to relapsed/refractory fl
-
1:59
optimal treatment sequencing for relapsed/refractory myeloma
-
5:47
choosing therapy for relapsed/refractory fl
-
56:41
approaches to relapse therapy in multiple myeloma: recent advancements and treatment strategies
-
9:37
day by day | my cancer treatment begins | acute myeloid leukemia
-
1:16:23
optimising the management of multiple myeloma in the early relapsed/refractory setting
-
5:06
treatment of relapsed/refractory mhcc
-
3:58
approaching therapy for relapsed/refractory cll
-
5:24
treating relapsed/refractory nsclc after i-o therapy
-
6:08
relapsed/refractory dlbcl treatment landscape
-
3:44
relapsed/refractory her2 mbc: future treatment landscape
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
27:51
relapsed/refractory approaches - dr. mj kersten
-
5:22
sequencing therapies for relapsed/refractory cll
-
4:58
choosing second-line therapy for relapsed/refractory fl
-
7:39
data on fda approved therapy for relapsed/refractory sclc
-
1:08:22
transforming the treatment paradigm for patients with relapsed/ refractory adult b cell all
-
9:14
emerging therapies for relapsed/refractory multiple myeloma
-
56:02
transforming the treatment paradigm for patients with relapsed/ refractory adult b cell all
-
5:27
car t-cell therapy: relapsed/refractory all